Breast Cancer Trial, Recruiting (NCT05190978)

Breast Cancer Trial, Recruiting NCT05190978 Sponsor: University of California, Los Angeles Condition: Breast Cancer

Printed from Voxsanity (voxsanity.com.au) — NCT05190978 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Breast Cancer

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

Women between the ages of 22 and 75 who are having one or both breasts reconstructed immediately after mastectomy, using a tissue expander placed in front of the chest muscle.
Both preventative mastectomies (for people at high risk of breast cancer) and mastectomies to treat breast cancer are acceptable reasons for the surgery.
Both nipple-sparing and skin-sparing mastectomy techniques are acceptable.

Who may not be able to join:

People where the surgeon finds during the operation that the skin left after the mastectomy is too thin or not healthy enough for the planned type of reconstruction.
People having reconstruction on both breasts where the other breast is being reconstructed using a method that places the implant under the chest muscle.
People whose reconstruction plan involves placing a permanent implant directly, without first using a tissue expander.
People who are pregnant.
People having reconstruction at a later date, rather than at the time of the mastectomy.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 9 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Michael Delong, MD, University of California, Los Angeles

Phone: (310) 825-5510

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT05190978

Sponsor: University of California, Los Angeles

Phase: Not Applicable

Status: Recruiting

Condition: Breast Cancer

Trial contact: (310) 825-5510

More information: https://clinicaltrials.gov/study/NCT05190978

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

Women between the ages of 22 and 75 who are having one or both breasts reconstructed immediately after mastectomy, using a tissue expander placed in front of the chest muscle.
Both preventative mastectomies (for people at high risk of breast cancer) and mastectomies to treat breast cancer are acceptable reasons for the surgery.
Both nipple-sparing and skin-sparing mastectomy techniques are acceptable.

Who may not be able to join:

People where the surgeon finds during the operation that the skin left after the mastectomy is too thin or not healthy enough for the planned type of reconstruction.
People having reconstruction on both breasts where the other breast is being reconstructed using a method that places the implant under the chest muscle.
People whose reconstruction plan involves placing a permanent implant directly, without first using a tissue expander.
People who are pregnant.
People having reconstruction at a later date, rather than at the time of the mastectomy.

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 9 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

University of California, Los Angeles

Registry

ClinicalTrials.gov

Start date

20 October 2022

Est. completion

30 April 2027

Where this trial is recruiting

🇺🇸 United States

Primary endpoints

Safety - Major Complications; Effectiveness - BREASTQ

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 9 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov